Palisade Historical Income Statement
| PALI Stock | USD 0.71 0.01 1.07% |
Historical analysis of Palisade Bio income statement accounts such as Gross Profit of 128.8 K, Other Operating Expenses of 15.4 M, Research Development of 8.9 M or Total Operating Expenses of 15.4 M can show how well Palisade Bio performed in making a profits. Evaluating Palisade Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Palisade Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Palisade Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Palisade Bio is a good buy for the upcoming year.
Palisade |
About Palisade Income Statement Analysis
Palisade Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Palisade Bio shareholders. The income statement also shows Palisade investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Palisade Bio Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Palisade Bio. It is also known as Palisade Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Palisade Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Palisade Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.As of now, Palisade Bio's Total Other Income Expense Net is increasing as compared to previous years. The Palisade Bio's current Income Tax Expense is estimated to increase to about 19.3 K, while Depreciation And Amortization is projected to decrease to 4,370.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 13K | 15K | 17.3K | 16.4K | Depreciation And Amortization | 167K | 4K | 4.6K | 4.4K |
Palisade Bio income statement Correlations
Click cells to compare fundamentals
Palisade Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Palisade Bio income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 146K | 168K | 167K | 4K | 4.6K | 4.4K | |
| Interest Expense | 235K | 2.4M | 13K | 15K | 17.3K | 16.4K | |
| Selling General Administrative | 6.2M | 9.3M | 8.8M | 6.2M | 7.1M | 6.6M | |
| Total Revenue | 15.4K | 13.5K | 0.0 | 250K | 225K | 165.4K | |
| Gross Profit | (132.5K) | (168K) | (167K) | 250K | 225K | 128.9K | |
| Other Operating Expenses | 9.3M | 41.9M | 15.3M | 13.3M | 15.3M | 15.4M | |
| Operating Income | (9.3M) | (41.9M) | (15.7M) | (13.1M) | (11.8M) | (12.4M) | |
| Ebit | (10.1M) | (24.2M) | (15.5M) | (12.3M) | (11.1M) | (11.6M) | |
| Research Development | 3.1M | 32.5M | 6.5M | 6.9M | 7.9M | 8.9M | |
| Ebitda | (9.9M) | (24.1M) | (15.3M) | (12.3M) | (11.1M) | (11.6M) | |
| Total Operating Expenses | 9.3M | 41.9M | 15.3M | 13.3M | 15.3M | 15.4M | |
| Income Before Tax | (10.3M) | (26.6M) | (14.3M) | (12.3M) | (11.1M) | (11.6M) | |
| Total Other Income Expense Net | (1.0M) | 15.2M | 1.5M | 770K | 885.5K | 929.8K | |
| Net Income | (10.6M) | (27.3M) | (12.8M) | (12.3M) | (11.1M) | (11.6M) | |
| Income Tax Expense | 248K | 655K | (1.5M) | 16K | 18.4K | 19.3K | |
| Net Income Applicable To Common Shares | (10.1M) | (10.3M) | (26.6M) | (14.5M) | (13.1M) | (13.7M) |
Currently Active Assets on Macroaxis
When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.